Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is a first-line indicator for various medically-relevant situations, ranging from chemotherapy management to the detection of life threatening infections worldwide. This test is currently invasive and not readily accessible - it requires patient travel, blood draws and laboratory infrastructure. Based on MIT research, Leuko is re-imagining the way to perform these tests without extracting blood and in a portable device.
| Website | https://leuko.com/ |
| Employees | 15 (11 on RocketReach) |
| Founded | 2017 |
| Address | 678 Massachusetts Ave, Cambridge, Massachusetts 02139, US |
| Phone | +1 502-384-2667 |
| Industry | Retail, Medical Equipment Manufacturing |
| Keywords | Infection Detection, Blood Cell Analysis, Healthcare Technology, Medical Technology, Health Diagnostics, Precision Medicine, Disease Detection, Patient Monitoring, Medical Sensors, Diagnostic Tools, Health Monitoring |
| Competitors | Lilly India, Celerion, Covance, Labcorp, Invicro, Medidata Solutions, PPD, Veristat, George Clinical, Parexel +43 more (view full list) |
| SIC | SIC Code 38 Companies, SIC Code 384 Companies |
| NAICS | NAICS Code 33 Companies, NAICS Code 334 Companies |
Looking for a particular Leuko employee's phone or email?
Carlos Castro-Gonzalez is the Co-Founder and CEO of Leuko.
11 people are employed at Leuko.
Leuko is based in Cambridge, Massachusetts.
The NAICS codes for Leuko are [33, 334].
The SIC codes for Leuko are [38, 384].